We also determined if treatment in vitro with prostaglandin E2 (PGE2), which can activate β-catenin, could rescue the defective interaction between active Foxo3a and β-catenin in mutant LT-CML stem cells [35]. Here, FOXO3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.